1. A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps 
Francisco Lopez-Jimenez, MD, MSc, Vinaya Simha, MD, Randal J. Thomas, MD, MSc, Thomas G. Allison, PhD, MPH, Ananda Basu, MD, Regis Fernandes, MD, R. Todd Hurst, MD, Stephen L. Kopecky, MD, Iftikhar J. Kullo, MD, Sharon L. Mulvagh, MD, Warren G. Thompson, MD, Jorge F. Trejo-Gutierrez, MD, MHS, R. Scott Wright, MD 
Mayo Clinic Proceedings 
Volume 89, Issue 9, Pages (September 2014)
DOI: /j.mayocp
Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure
Proposed algorithm when considering initiating statins for cholesterol treatment in atherosclerotic cardiovascular disease (ASCVD) risk reduction. ABI = ankle-brachial index; AHA = American Heart Association; CAD = coronary artery disease; CV = cardiovascular; DM = diabetes mellitus; HF = heart failure; HIV = human immunodeficiency virus; LDL-C = low-density lipoprotein cholesterol; NYHA = New York Heart Association; RCT = randomized controlled trial; Rx = treatment; TLC = therapeutic lifestyle change.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions